SecBot SecBot
8-K ·Filed Nov 4, 2026

PRCT

PROCEPT BioRobotics Corp
NEUTRAL
Impact 5/10
Horizonweeks Processed12d 10h ago SEC0001588978-26-000036
8-K Item 2.02: Earnings release
Actionable Insight • Neutral

Revenue slightly missed consensus while EPS missed by $0.07, but the company reaffirmed full-year guidance and showed strong procedure growth and handpiece ASP improvement. Monitor Q4 results for progress toward the $390M-$410M revenue target and the path to breakeven.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$20.27
T+0 close · Nov 4, 2026 · via day close
Latest settled
+15.98%
T+5 · $23.51 · next T+20 in 17d
Vs SPY
+12.69%
α at T+5
Latest observation
+18.90%
T+6 · FF3 residual α
  1. T+0 · Nov 5 $20.27entry
  2. T+1 · 11d ago +1.73%α +1.41% · $20.62
  3. T+5 · 5d ago +15.98%α +12.69% · $23.51
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

The company reaffirmed its full-year 2026 revenue guidance of $390M-$410M and its adjusted EBITDA loss guidance of $35M-$30M, while U.S. procedure growth of 22% and handpiece ASP increases of 12% showed positive operational trends.

Key Financial Metrics

Revenue
$98.3M
est $100.5M · -2.2% · +18.0% YoY
Guidance
$390M-$410M
maintained
Gross Margin
66%

Key Facts

  • Q3 2026 total revenue $98.3M, up 18% YoY from $83.3M
  • U.S. procedures over 13,400, up approximately 22% YoY
  • U.S. handpiece ASP approximately $3,570, up 12% YoY
  • International revenue $12.5M, up 32% YoY
  • Gross margin 66% vs 65% in prior year period
  • Full-year 2026 revenue guidance reaffirmed at $390M-$410M
  • Full-year 2026 adjusted EBITDA loss guidance narrowed to $35M-$30M
  • Cash and equivalents $221.4M as of September 30, 2026

Financial Impact

Revenue $98.3M vs consensus $100.5M; EPS $(0.46) vs consensus $(0.39); net loss widened to $26.5M from $21.4M YoY

revenueepsnet lossadjusted EBITDA

Segment Breakdown

SegmentRevenueGrowth
U.S. System sales and rentals$24.7M0.0%
U.S. Handpieces and other consumables$53.9M+21.0%
U.S. Service$7.3MNot reported
International System sales and rentals$4.5MNot reported
International Handpieces and other consumables$7.0MNot reported
International Service$989.0KNot reported

Risk Factors

  • EPS and revenue both missed consensus estimates
  • Operating expenses grew 20% YoY to $92.5M, outpacing revenue growth
  • Net loss widened to $26.5M from $21.4M YoY
  • Cash burn continues; cash balance declined to $221.4M from $289.5M at year-end 2025

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
48% bullish (21 analysts)

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001588978-26-000036
Document: prct-20261104.htm0001588978-26-000036
Document: 0001588978-26-000036-index-headers.html0001588978-26-000036
Document: 0001588978-26-000036-index.html0001588978-26-000036
Document: 0001588978-26-000036.txt0001588978-26-000036
8-K Data (Synthetic)0001588978-26-000036

Track record

16 reports on PRCT

Performance horizon

4 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +22.73% at T+60 after the Feb 26, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 6, 202610d ago 144 Neutral 2/10 Entry $20.62 Now $23.54 +14.16% settles Feb 4
  2. Nov 4, 202612d ago 8-K Neutral 5/10 Viewing Entry $20.27 Now $23.54 +16.13% settles Feb 3
  3. Oct 30, 202617d ago SC 13G/A Neutral 2/10 Entry $19.20 Now $23.54 +22.60% settles Jan 28
  4. Oct 2, 20266w ago 8-K Neutral 2/10 Entry $17.82 Now $23.54 +32.10% settles Dec 30
  5. Sep 24, 20267w ago 8-K Neutral 3/10 Entry $17.20 Now $23.54 +36.86% settles Dec 21
  6. Aug 10, 202614w ago Insider Buy Bullish 5/10 Entry $21.71 to $19.98 Now $23.54 +8.43% ▼ −7.99% −6.09% vs SPY
  7. Jun 11, 202622w ago Institutional Cluster Mixed 4/10 Entry $27.69 to $21.35 Now $23.54 −14.99% ▼ −22.90% −26.72% vs SPY
  8. Jun 10, 202622w ago Insider Cluster Neutral 2/10 Entry $27.69 to $21.35 Now $23.54 −14.99% ▼ −22.90% −26.72% vs SPY
  9. Jun 10, 202622w ago Insider Cluster Neutral 2/10 Entry $27.69 to $21.35 Now $23.54 −14.99% ▼ −22.90% −26.72% vs SPY
  10. Jun 10, 202622w ago Insider Cluster Neutral 2/10 Entry $27.69 to $21.35 Now $23.54 −14.99% ▼ −22.90% −26.72% vs SPY
Showing 10 of 16

US Market Status

Market Closed · Opens in 6h 39m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 4, 2026